A new study has discovered a possible biomarker linked to multiple sclerosis disease progression that could help identify ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced a ...

Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...

Jimmy Kimmel Live! will reportedly no longer feature nightly musical performances. The decision comes months after the show ...

The new 2.5D action-platformer title SPEAR is set for launch on Xbox Series X|S, as the game will arrive on the platform ...

Warner Bros Discovery rejected Paramount Skydance's amended $108.4 billion hostile bid on Wednesday, potentially clearing a ...

This week's top new movies across the biggest streaming services include a summer-themed rom-com on Netflix and bone-chilling ...

Screen looks at the potential impact on the indie sector of the WBD sale, the launch of TIFF: The Market, and whether there ...

A ‘stunning’ 2025 sci-fi sequel film that fans said is ‘better than expected’ has arrived on Disney+ just months after it was ...

Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc.

From health care initiatives to public utilities, there's no shortage of bills that took effect at the start of the new year.